Research unveiled that a drug therapy using Rituxan (Rituximab) lessens the number of lesions that form along the nerve fibers of the brain of patients with multiple sclerosis.

Rituxan, used to treat rheumatoid arthritis and non-Hodgkin's lymphoma, provides an important effect in treating multiple sclerosis based on clinical trial

Americans are spending more on treating back and neck pain than almost any other medical condition, a new research suggests. Total spending on spine treatments in the United States totalled nearly $86 billion in 2005, a rise of 65 percent from 1997.

That is in line with annual expenditures for major conditions, including cancer, arthritis, and diabetes

Obese patients demanding for elective surgery want to be given equal chances to go under the knife compared with their normal-weight counterparts.

Overweight British patients said they should not be discriminated against or worse, made to pay for their own operation on account of their size

In one of the largest drug settlements ever, U.S. drug manufacturer Merck and Co. on Friday was slapped with $4.85 billion in fines to settle up to 50,000 personal injury claims linked to its arthritis treatment Vioxx.

Vioxx led to heart attacks or ischemic strokes, where blood flow is blocked to the brain in many people who filed for the lawsuit. The company however pulled the drug from the market Sept. 30, 2004, after its researchers determined that it doubled risk of heart attacks and strokes

Regular use of over-the-counter medicines such as Ibuprofen lowers a person's risk of Parkinson's disease, according to a new study.

The findings support earlier studies which have suggested that inflammation-fighting drugs can prevent Parkinson's and, perhaps, other neurodegenerative diseases as well